Complementary medicine: Where is the evidence?

Journal of Family Practice

Volumn 52, Issue 8, 2003, Pages 630-634

  Ernst, Edzard ^a  

^a PENINSULA MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AESCULUS HIPPOCASTANUM EXTRACT; ARTICHOKE EXTRACT; CERNITIN; HERBACEOUS AGENT; HYPERICUM PERFORATUM EXTRACT; KAVA; OSCILLOCOCCINUM EXTRACT; PLACEBO; PYGEUM AFRICANUM EXTRACT; SABAL EXTRACT; SITOSTEROL; TANACETUM PARTHENIUM EXTRACT; UNCLASSIFIED DRUG;

ACUPUNCTURE; ACUPUNCTURE ANALGESIA; ALTERNATIVE MEDICINE; ANXIETY DISORDER; ARTERY DISSECTION; ARTICHOKE; ARTICLE; ASTHMA; CHRONIC VEIN INSUFFICIENCY; CLINICAL TRIAL; COCHRANE LIBRARY; DEPRESSION; ELBOW; EVIDENCE BASED MEDICINE; GENERAL PRACTICE; HEADACHE; HERBAL MEDICINE; HOMEOPATHY; HUMAN; HYPERCHOLESTEROLEMIA; INFLUENZA; LOW BACK PAIN; MANIPULATIVE MEDICINE; MASSAGE; MEDICAL RESEARCH; MIGRAINE; NERVE INJURY; OSCILLICOCCINUM; OSTEOARTHRITIS; PAIN; PROSTATE HYPERTROPHY; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; TOXICITY;

COMPLEMENTARY THERAPIES; EVIDENCE-BASED MEDICINE; HUMANS; RESEARCH DESIGN; REVIEW LITERATURE;

EID: 0041591069     PISSN: 00943509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Institut für Demoskopie Allensbach. Naturheilmittel: Wichtigste Erkenntnisse aus Allensbacher Trendstudien. [Natural cures: The most important conclusions from Allensbach trend studies.] Available at: www.demoskopie.de. Accessed on May 27, 2003.
2. Eisenberg DM, David RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 1998; 280:1569-1575.
3. Steyer TE, Freed GL, Lantz PM. Medicaid reimbursement for alternative therapies. Alt Ther Health Med 2002; 8:84-88.
4. Marcus DM. Alternative medicine and the Arthritis Foundation. Arthritis Rheum 2002; 47:5-7.
5. Fitzcharles M. Is it time for rheumatologists to rethink the use of manual therapies? J Rheumatol 2002; 29:1117-1120.
6. Charlton BG. Randomized trials in alternative/complementary medicine. Q J Med 2002; 95:643-645.
7. Barnes J, Abbot NC, Harkness E, Ernst E. Articles on complementary medicine in the mainstream medical literature: an investigation of MEDLINE, 1966 through 1996. Arch Intern Med 1999; 159:1721-1725.
8. Olsen O, Middleton P, Ezzo J, et al. Quality of Cochrane reviews: assessment of sample from 1998. BMJ 2001; 323:829-832.
9. Jadad AR, Moher M, Browman GP, et al. Systematic reviews and meta-analyses on treatment of asthma: critical evaluation. BMJ 2000; 320:537-540.
10. The Cochrane Library [database online]. Oxford, UK: Update Software; 2002. Available at: www.cochranelibrary.com. Accessed on May 23, 2003.
11. Vickers A. Evidence-based medicine and complementary medicine. ACPJ Club 1999; 130:A13-14.
12. Linde K. St John's wort for depression. The Cochrane Library 2000; 4:1-17.
13. Ernst E. Funding research into complementary medicine: the situation in Britain. Complement Ther Med 1999; 7:250-253.
14. Linde K, Willich SN. How objective are systematic reviews? Differences between reviews on complementary medicine. J R Soc Med 2003; 96:17-22.
15. Ernst E. How objective are systematic reviews? J R Soc Med 2003; 96:56-57.
16. Tonelli MR, Callahan TC. Why alternative medicine cannot be evidence-based. Acad Med 2001; 76:1213-1220.
17. Jonas WB. The evidence, house: how to build an inclusive base for complementary medicine. West J Med 2001; 175:79-80.
18. Walach H. The efficacy paradox in randomized controlled trials of CAM and elsewhere: beware of the placebo trap. J Altern Complement Med 2001; 7:213-218.
19. Redwood D. Methodological changes in the evaluation of complementary and alternative medicine: issued raised by Sherman et al and Hawk et al. J Altern Complement Med 2002; 8:5-6.
20. Puchalski CM. Reconnecting the science and art of medicine. Acad Med 2001; 76:1224-1225.
21. Bodeker G, Kronenberg F. A public health agenda for traditional, complementary, and alternative medicine. Am J Public Health 2002; 92:1582-1591.
22. Vickers A, Cassileth B, Ernst E, et al. How should we research unconventional therapies? A panel report from the conference on Complementary and Alternative Medicine Research Methodology, National Institute of Health. Int J Technol Assess Health Care 1997; 13:111-121.
23. Ernst E, Pittler MH, Stevinson C, White AR. The desktop guide to complementary and alternative medicine. London: Mosby; 2001.
24. Bloom BS, Retbi A, Dahan S, Jonsson E. Evaluation of randomized controlled trials on complementary and alternative medicine. Int J Technol Assess Health Care 2000; 16:13-21.
25. Linde K, Jonas WB, Melchart D, Willich S. The methodological quality of randomised controlled trials of homeopathy, herbal medicines and acupuncture. Int J Epidemiol 2001; 30:526-531.
26. Moher D, Sampson M, Campbell K, et al. Assessing the quality of reports of randomised trials in pediatric complementary and alternative medicine. BMC Pediatr 2002; 2:1-6.
27. Ernst E. Risks associated with complementary therapies. In MNG Dukes and JR Aronson, eds, Meyler's Side Effects of Drugs. 14th ed. Oxford and New York: Elsevier Science; 2000:1649-1681.
28. Schmidt K, Ernst E. Aspects of MMR. Survey shows that some homeopaths and chiropractors advise against MMR. BMJ 2002; 325:597.
29. White AR, Ernst E. Economic analysis of complementary medicine a systematic review. Complement Ther Med 2000; 8:111-118.
30. Yuan C-S, Bieber EJ, eds. Textbook of complementary and alternative medicine. Boca Raton, Fla: Parthenon; 2003.